Estrogen enhances expression of the complement C5a receptor and the C5a-agonist evoked calcium influx in hormone secreting neurons of the hypothalamus

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 846-856

  Farkas, Imre ^a   Varju, Patricia ^a   Szabo, Emese ^a   Hrabovszky, Erik ^a   Okada, Noriko ^b   Okada, Hidechika ^c   Liposits, Zsolt ^a,d  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

Author keywords

Complement C5a receptor; Estrogen; Hypothalamus; Neurosecretory neurons

Indexed keywords

CALCIUM ION; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A RECEPTOR; ESTROGEN; GONADORELIN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR HYPOTHALAMUS; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; GIANT CELL; HORMONE RELEASE; MOUSE; NEUROSECRETORY CELL; NONHUMAN; PATCH CLAMP; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUPRAOPTIC NUCLEUS; WHOLE CELL;

ANIMALS; BASAL NUCLEUS OF MEYNERT; CALCIUM; CELL LINE; ELECTROPHYSIOLOGY; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONES; HYPOTHALAMUS; MALE; MICE; NEURONS; NEUROSECRETORY SYSTEMS; PATCH-CLAMP TECHNIQUES; PHENOTYPE; RATS; RATS, WISTAR; RECEPTOR, ANAPHYLATOXIN C5A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 38349127867     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.09.014     Document Type: Article

References (53)

1. Baranyi L., Campbell W., and Okada H. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat. Med. 9 (1995) 894-901
2. Baranyi L., Campbell W., and Okada H. Antisense homology boxes in C5a receptor and C5a anaphylatoxin. J. Immunol. 157 (1996) 4591-4601
3. Blatteis C.M. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol. Ther. 111 (2006) 194-223
4. Blatteis C.M., and Sehic E. Cytokines and fever. Ann. N. Y. Acad. Sci. 840 (1998) 608-618
5. Brown T.J., Naftolin F., and Maclusky N.J. Sex differences in estrogen receptor binding in the rat hypothalamus: effects of subsaturating pulses of estradiol. Brain Res. 578 (1992) 129-134
6. Che F.Y., Yuan Q., Kalinina E., and Fricker L.D. Peptidomics of Cpe fat/fat mouse hypothalamus: effect of food deprivation and exercise on peptide levels. J. Biol. Chem. 280 (2005) 4451-4461
7. Chen S., Nilsen J., and Brinton R.D. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 147 (2006) 5303-5313
8. Christoffel J., Rimoldi G., and Wuttke W. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment. J. Endocrinol. 188 (2006) 397-405
9. de Carvalho Borges B., Carnio E.C., Elias L.L.K., Antunes-Rodrigues J., Branco L.G.S., and da Rocha M.J.A. Lesion of the anteroventral third ventricle (AV3V) reduces hypothalamic activation and hypophyseal hormone secretion induced by lipopolysaccharide in rats. Brain Res. 115 (2006) 83-91
10. Farkas I., Baranyi L., Liposits Zs., Yamamoto T., and Okada H. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 86 (1998) 903-911
11. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Zs., Yamamoto T., and Okada H. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507 (1998) 679-687
12. Farkas I., Baranyi L., Kaneko Y., Liposits Zs., Yamamoto T., and Okada H. C5a receptor expression by TGW neuroblastoma cells. Neuroreport 10 (1999) 3021-3025
13. Farkas I., Takahashi M., Fukuda A., Yamamoto N., Akatsu H., Baranyi L., Tateyama H., Yamamoto T., Okada N., and Okada H. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. J. Immunol. 170 (2003) 5764-5771
14. Farkas I., Varju P., and Liposits Z. Estrogen modulates potassium currents and expression of the Kv4.2 subunit in GT1-7 cells. Neurochem. Int. 50 (2007) 619-627
15. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Gotze O., and Morgan B.P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155 (1995) 4882-4889
16. Gasque P., Singhrao S.K., Neal J.W., Gotze O., and Morgan B.P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150 (1997) 31-41
17. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., and Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49 (2000) 171-186
18. Giusti-Paiva A., De Castro M., Antunes-Rodrigues J., and Carnio E.C. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit. Care Med. 30 (2002) 1306-1310
19. Haddad J.J., Saade N.E., and Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 133 (2002) 1-19
20. He D., Sato I., Kimura F., and Akema T. Lipopolysaccharide inhibits luteinizing hormone release through interaction with opioid and excitatory amino acid inputs to gonadotropin-releasing hormone neurones in female rats: possible evidence for a common mechanism involved in infection and immobilization stress. J. Neuroendocrinol. 15 (2003) 559-563
21. Hoffman N.W., Tasker J.G., and Dudek F.E. Immunohistochemical differentiation of electrophysiologically defined neuronal populations in the region of the rat hypothalamic paraventricular nucleus. J. Comp. Neurol. 307 (1991) 405-416
22. Karpuzoglu E., and Ahmed A. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide 15 (2006) 177-186
23. Karsch F.J., Battaglia D.F., Breen K.M., Debus N., and Harris T.G. Mechanisms for ovarian cycle disruption by immune/inflammatory stress. Stress 5 (2002) 101-112
24. Konteatis Z.D., Siciliano S.J., Van Riper G., Molineaux C.J., Pandya S., Fischer P., Rosen H., Mumford R.A., and Springer M.S. Development of C5a receptor antagonists. J. Immunol. 153 (1994) 4200-4205
25. Kovacs E.J. Aging, traumatic injury, and estrogen treatment. Exp. Gerontol. 40 (2005) 549-555
26. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., and Weiner R.I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5 (1990) 1-10
27. Morale M.C., Serra P.A., L'episcopo F., Tirolo C., Caniglia S., Testa N., Gennuso F., Giaquinta G., Rocchitta G., Desole M.S., Miele E., and Marchetti B. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 138 (2006) 869-878
28. Nordell V.L., Scarborough M.M., Buchanan A.K., and Sohrabji F. Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol. Aging 24 (2003) 733-743
29. O'Barr S.A., Caguioa J., Gruol D., Perkins G., Ember J.A., Hugli T.E., and Cooper N.R. Neuronal expression of a functional receptor for the C5a complement activation fragment. J. Immunol. 166 (2001) 4154-4162
30. Perlik V., Li Z., Goorha S., Ballou L.R., and Blatteis C.M. LPS-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R332-R339
31. Riedemann N.C., Guo R.F., Laudes I.J., Keller K., Sarma V.J., Padgaonkar V., Zetoune F.S., and Ward P.A. C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16 (2002) 887-888
32. Riedemann N.C., Guo R.F., Hollmann T.J., Gao H., Neff T.A., Reuben J.S., Speyer C.L., Sarman J.V., Wetsel R.A., Zetoune F.S., and Ward P.A. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 18 (2004) 370-372
33. Rother K., Till G.O., and Hansch G.M. The Complement System. second ed. (1998), Springer Verlag, Berlin/Heidelberg/New York
34. Schupf N., Williams C.A., Berkman A., Cattell W.S., and Kerper L. Binding specificity of presynaptic action of anaphylatoxin C5a in rat brain. Brain Behav. Immun. 3 (1989) 28-38
35. Sehic E., Li S., Ungar A.L., and Blatteis C.M. Complement reduction impairs the febrile response of guinea pigs to endotoxin. Am. J. Physiol. 274 Pt2 (1998) R1594-R1603
36. Shen Y., Li R., McGeer E.G., and McGeer P.L. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769 (1997) 391-395
37. Sohrabji F. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Ann. N. Y. Acad. Sci. 1052 (2005) 75-90
38. Soucy G., Boivin G., Labrie F., and Rivest S. Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. J. Immunol. 174 (2005) 6391-6398
39. Stahel P.F., Frei K., Eugster H., Fontana A., Hummel K.M., Wetsel R.A., Ames R.S., and Barnum S.R. TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J. Immunol. 159 (1997) 861-869
40. Stahel P.F., Kossmann T., Morganti-Kossmann M.C., Hans V.H.J., and Barnum S.R. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Mol. Brain Res. 50 (1997) 205-212
41. Strohmeyer R., Shen Y., and Rogers J. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Mol. Brain Res. 81 (2000) 7-18
42. Suter K.J., Song W.J., Sampson T.L., Wuarin J.P., Saunders J.T., Dudek F.E., and Moenter S.M. Genetic targeting of green fluorescent protein to gonadotropin-releasing hormone neurons: characterization of whole-cell electrophysiological properties and morphology. Endocrinology 141 (2000) 412-419
43. Suzuki S., Brown C.M., and Wise P.M. Mechanisms of neuroprotection by estrogen. Endocrine 29 (2006) 209-215
44. Tasker J.G., and Dudek F.E. Electrophysiological properties of neurones in the region of the paraventricular nucleus in slices of rat hypothalamus. J. Physiol. 434 (1991) 271-293
45. Terai K., Walker D.G., McGeer E.G., and McGeer P.L. Neurons express proteins of the classical pathway in Alzheimer disease. Brain Res. 769 (1997) 385-390
46. Thakur M.K., and Sharma P.K. Transcription of estrogen receptor alpha and beta in mouse cerebral cortex: effect of age, sex 17beta-estradiol and testosterone. Neurochem. Int. 50 (2007) 314-321
47. Thomas A., Gasque P., Vaudry D., Gonzalez B., and Fontaine M. Expression of a complete and functional complement system by human neuronal cells in vitro. Int. Immunol. 12 (2000) 1015-1023
48. Turgeon J.L., McDonnell D.P., Martin K.A., and Wise P.M. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304 (2004) 1269-1273
49. VanBeek J., Bernaudin M., Petit E., Gasque P., Nouvelot A., MacKenzie E.T., and Fontaine M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161 (2000) 373-382
50. Williams C.A., Schupf N., and Hugli T.E. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9 (1985) 29-40
51. Woodruff T.M., Crane J.W., Proctor L.M., Buller K.M., Shek A.B., de Vos K., Pollitt S., Williams H.M., Shiels I.A., Monk P.N., and Taylor S.M. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 20 (2006) 1407-1417
52. Xia Y., and Krukoff T.L. Differential neuronal activation in the hypothalamic paraventricular nucleus and autonomic/neuroendocrine responses to I.C.V. endotoxin. Neuroscience 121 (2003) 219-231
53. Yang R.C., Shih H.C., Hsu H.K., Chang H.C., and Hsu C. Estradiol enhances the neurotoxicity of glutamate in GT1-7 cells through an estrogen receptor-dependent mechanism. Neurotoxicology 24 (2003) 65-73